Acetazolamide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69367-209 -
Package NDC
69367-209-01 -
Application number
ANDA090779 -
SPL ID
c04410c8-e55f-4f15-a10d-9d94476bde16 -
SPL set ID
417b1df2-63bc-473c-9e02-5f93dd45554d -
UNII
O3FX965V0I -
RxCUI
562524
What the source publishes
- Labeler
- Westminster Pharmaceuticals, LLC
- Active ingredients
- Acetazolamide
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Acetazolamide",
"splId": "c04410c8-e55f-4f15-a10d-9d94476bde16",
"labels": [
{
"setId": "417b1df2-63bc-473c-9e02-5f93dd45554d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=417b1df2-63bc-473c-9e02-5f93dd45554d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=417b1df2-63bc-473c-9e02-5f93dd45554d"
}
],
"routes": [
"ORAL"
],
"labeler": "Westminster Pharmaceuticals, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01)",
"package_ndc": "69367-209-01",
"identifierStatus": "well-formed",
"marketing_end_date": "20280501",
"marketing_start_date": "20230420"
}
],
"productId": "69367-209_c04410c8-e55f-4f15-a10d-9d94476bde16",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "69367-209",
"deaSchedule": null,
"genericName": "Acetazolamide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20280501",
"activeIngredients": [
{
"name": "ACETAZOLAMIDE",
"strength": "500 mg/1"
}
],
"applicationNumber": "ANDA090779",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230420",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175517",
"N0000000235",
"M0020790"
],
"upc": [
"0369367209014"
],
"unii": [
"O3FX965V0I"
],
"rxcui": [
"562524"
],
"spl_set_id": [
"417b1df2-63bc-473c-9e02-5f93dd45554d"
],
"pharm_class_cs": [
"Sulfonamides [CS]"
],
"pharm_class_epc": [
"Carbonic Anhydrase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Carbonic Anhydrase Inhibitors [MoA]"
],
"manufacturer_name": [
"Westminster Pharmaceuticals, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69367-209_c04410c8-e55f-4f15-a10d-9d94476bde16"